Biora Therapeutics Announces Five Abstracts Accepted at American College of Gastroenterology Annual Scientific Meeting 2022
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of five abstracts for presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting. ACG’s mission is to advance world-class care for patients with gastrointestinal disorders through excellence, innovation, and advocacy in the areas of scientific investigation, education, prevention, and treatment. The 2022 ACG Annual Scientific Meeting will be held in Charlotte, NC and virtually from October 21–26, 2022.
Targeted Therapeutics Platform Poster Presentations
Systemic Therapeutics Platform Poster Presentations
All research presented at ACG 2022, including abstract titles, is strictly embargoed until Sunday, October 23 at 3:30 PM, EDT. Accepted abstracts will appear in a special supplement to the October 2022 issue of The American Journal of Gastroenterology. Poster presentations will also be made available on the Biora Therapeutics website.
About Biora Therapeutics
Safe Harbor Statement or Forward-Looking Statements
Biora Therapeutics expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.